Correction: A Modified Chronic Infection Model for Testing Treatment of Staphylococcus aureus Biofilms on Implants
ثبت نشده
چکیده
The following information is missing from the Funding section: “Additional funding from Pfizer Investigator-initiated research (IIR) Grant, 2009 & Pfizer Antibacterial EUROPE ASPIRE 2010.” The complete, correct Funding section is: “Nis Jørgensen is supported by a PhD grant from the Faculty of Health Science, University of Aarhus, Denmark. Additional funding from Pfizer Investigator-initiated research (IIR) Grant, 2009 & Pfizer Antibacterial EUROPE ASPIRE 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Additionally, the second author’s middle initial is missing. The full name for this author is: Rikke L. Meyer. The correct citation is: Jørgensen NP, Meyer RL, Dagnæs-Hansen F, Fuursted K, Petersen E (2014) A Modified Chronic Infection Model for Testing Treatment of Staphylococcus aureus Biofilms on Implants. PLoS ONE 9(10): e103688. doi:10.1371/journal.pone. 0103688
منابع مشابه
A Modified Chronic Infection Model for Testing Treatment of Staphylococcus aureus Biofilms on Implants
Bacterial biofilms causing implant-associated osteomyelitis is a severe complication with limited antimicrobial therapy options. We designed an animal model, in which implant associated osteomyelitis arise from a Staphylococcus aureus biofilm on a tibia implant. Two bioluminescently engineered (luxA-E transformed), strains of S. aureus were utilized, Xen29 and Xen31. Biofilm formation was asses...
متن کاملProteomics of Staphylococcus aureus biofilm matrix in a rat model of orthopedic implant-associated infection
The matrix proteins of Staphylococcus aureus biofilm have not been well defined. Previous efforts to identify these proteins were performed using in vitro systems. Here we use a proteomic approach to identify biofilm matrix proteins directly from infected bone implants using a rat model of orthopedic implant-associated S. aureus infection. Despite heavy presence of host proteins, a total of 28 ...
متن کاملThe Effect of Biosurfactant of Saccharomyces Cerevisiae on Biofilms Produced by Staphylococcus Aureus, Epidermidis and Saprophyticus: A Laboratory Study
Background and Objectives: Biosurfactants are amphiphilic molecules produced by microorganisms that due to surfactant activity, have several applications in different industries such as cleaning, emulsification, foaming and dispersion. The aim of this study was to investigate the effect of biosurfactant extracted from saccharomycess cerevisiae on biofilm formation of staphylococcus aureus (PTC...
متن کاملLysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
OBJECTIVES Staphylococcus aureus infections associated with indwelling devices can be very difficult to treat due to the recalcitrant nature of bacterial biofilms to conventional antibiotics. Lysostaphin has been shown to clear S. aureus biofilms in vitro, and in this study we determined whether lysostaphin could also eradicate established S. aureus biofilms on implanted jugular vein catheters ...
متن کاملHiding in Plain Sight: Interplay between Staphylococcal Biofilms and Host Immunity
Staphylococcus aureus and Staphylococcus epidermidis are notable for their propensity to form biofilms on implanted medical devices. Staphylococcal biofilm infections are typified by their recalcitrance to antibiotics and ability to circumvent host immune-mediated clearance, resulting in the establishment of chronic infections that are often recurrent in nature. Indeed, the immunomodulatory lif...
متن کامل